Selected Start-Ups (12/01)
In Vivo briefly summarizes the technologies of these recently founded companies: KetoCytonyx Inc., KMT Hepatech Inc., Nanosys Inc., Respirics Inc., Scion Pharmaceuticals Inc. and Somatocor Inc.
You may also be interested in...
Polpharma Biologics is making strategic moves to become a truly integrated CDMO by bringing its Dutch Bioceros subsidiary under the Polpharma Biologics brand.
With a proposed IPO, Gland Pharma’s parent company, Fosun Pharma, hopes to raise funds for its injectables business and possibly its COVID-19 vaccine. The move will also cut Chinese ownership against a backdrop of shaky relations between India and China. As investors warm up to pharma stocks, the timing seems right.
In a significant development, China proposes to strengthen the protection of new drugs through not only patent linkage but also patent compensation in the latest draft of its revised Patent Law.